- Home
- GPRK vs QSI Comparison
GPRK vs QSI Comparison
Compare GPRK & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- QSI
- Stock Information
- Founded
- GPRK 2002
- QSI 2013
- Country
- GPRK Colombia
- QSI United States
- Employees
- GPRK N/A
- QSI N/A
- Industry
- GPRK Oil & Gas Production
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- GPRK Energy
- QSI Health Care
- Exchange
- GPRK Nasdaq
- QSI Nasdaq
- Market Cap
- GPRK 535.0M
- QSI 633.2M
- IPO Year
- GPRK N/A
- QSI N/A
- Fundamental
- Price
- GPRK $9.93
- QSI $2.44
- Analyst Decision
- GPRK Strong Buy
- QSI Buy
- Analyst Count
- GPRK 2
- QSI 2
- Target Price
- GPRK $12.50
- QSI $3.25
- AVG Volume (30 Days)
- GPRK 760.2K
- QSI 59.3M
- Earning Date
- GPRK 03-05-2025
- QSI 02-27-2025
- Dividend Yield
- GPRK 4.25%
- QSI N/A
- EPS Growth
- GPRK N/A
- QSI N/A
- EPS
- GPRK 1.97
- QSI N/A
- Revenue
- GPRK $716,838,000.00
- QSI $2,266,000.00
- Revenue This Year
- GPRK N/A
- QSI $193.90
- Revenue Next Year
- GPRK $5.86
- QSI $173.18
- P/E Ratio
- GPRK $5.31
- QSI N/A
- Revenue Growth
- GPRK N/A
- QSI 232.26
- 52 Week Low
- GPRK $7.24
- QSI $0.61
- 52 Week High
- GPRK $11.72
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- GPRK 46.88
- QSI 51.15
- Support Level
- GPRK $10.71
- QSI $2.20
- Resistance Level
- GPRK $11.67
- QSI $2.68
- Average True Range (ATR)
- GPRK 0.69
- QSI 0.75
- MACD
- GPRK -0.03
- QSI -0.14
- Stochastic Oscillator
- GPRK 38.77
- QSI 15.05
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil and Argentina. The company generates revenue from the sale of crude oil, condensate and natural gas net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.